Neuroprotective Effects of Pinostrobin in a Rat Model of Kainic Acid-Induced Epilepsy
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27198579 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Jinatta Jittiwat und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Mahasarakham University, Mahasarakham 44000, Thailand. Hauptthemen laut MEDLINE: Flavanones, Kainic Acid, Epilepsy, Neuroprotective Agents. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Phayao, Thailand science research and innovation.
Abstract (Originalsprache)
Epilepsy is a serious neurological disorder characterized by recurrent seizures and neuronal loss. Prolonged seizure activity is associated with changes in apoptosis-related proteins, including Bcl-2-associated X protein (Bax) and caspase-3, as well as alterations in microglial and astroglial responses. This study investigated the neuroprotective effects of pinostrobin, a bioflavonoid, in a kainic acid (KA)-induced epilepsy model and examined its effects on apoptosis-related proteins. Pinostrobin (40 mg/kg) was administered orally once daily for 7 days before and 14 days after intracerebroventricular injection of KA. KA injection resulted in neuronal cell loss, increased number of ionized calcium-binding adapter molecule 1 (Iba1)-positive microglia, and reactive astrocytosis in the cornu ammonis 1 (CA1), cornu ammonis 3 (CA3), and hilar regions. These changes were accompanied by decreased levels of protein kinase B (Akt), phosphorylated-Akt (p-Akt), and the anti-apoptotic protein B-cell lymphoma 2 (Bcl-2), together with increased levels of Bax and caspase-3. Pinostrobin treatment significantly attenuated neuronal cell loss, reduced the number of Iba1-positive microglia, and increased glial fibrillary acidic protein (GFAP) immunoreactivity in the CA1, CA3, and hilar regions. Moreover, pinostrobin increased Akt, p-Akt, and Bcl-2 levels while decreasing Bax and caspase-3 levels. Collectively, these findings suggest that pinostrobin has potential neuroprotective effects in the KA-induced epilepsy model and is associated with changes in apoptosis-related proteins and glial responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine, Mahasarakham University, Mahasarakham 44000, Thailand.
- Division of Physiology, School of Medical Sciences, University of Phayao, Phayao 56000, Thailand.
- Division of Anatomy, School of Medical Sciences, University of Phayao, Phayao 56000, Thailand.
ORCID-Profile: Jinatta Jittiwat, Ratchaniporn Kongsui, Tichanon Promsrisuk, Sitthisak Thongrong
Förderung
- University of Phayao
- Thailand science research and innovation
Zitieren
APA
Jittiwat, J., Kongsui, R., Promsrisuk, T., Sriraksa, N., & Thongrong, S. (2026). Neuroprotective Effects of Pinostrobin in a Rat Model of Kainic Acid-Induced Epilepsy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27198579
Vancouver
Jittiwat J, Kongsui R, Promsrisuk T, Sriraksa N, Thongrong S. Neuroprotective Effects of Pinostrobin in a Rat Model of Kainic Acid-Induced Epilepsy. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27198579
BibTeX
@article{Jittiwat2026,
author = {Jittiwat, Jinatta and Kongsui, Ratchaniporn and Promsrisuk, Tichanon and Sriraksa, Napatr and Thongrong, Sitthisak},
title = {Neuroprotective Effects of Pinostrobin in a Rat Model of Kainic Acid-Induced Epilepsy},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27198579}
}
EUVIMED